Premium
Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation‐dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1
Author(s) -
Trarbach Ericka Barbosa,
Teles Milena Gurgel,
Costa Elaine Maria Frade,
Abreu Ana Paula,
Garmes Heraldo Mendes,
Guerra Gil,
Baptista Maria Tereza Matias,
De Castro Margaret,
Mendonca Berenice Bilharinho,
Latronico Ana Claudia
Publication year - 2010
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2009.03642.x
Subject(s) - hypogonadotropic hypogonadism , kallmann syndrome , gnrhr , multiplex ligation dependent probe amplification , endocrinology , medicine , exon , hypogonadotrophic hypogonadism , anosmia , point mutation , biology , compound heterozygosity , genetics , mutation , gene , gonadotropin releasing hormone , luteinizing hormone , hormone , disease , covid-19 , infectious disease (medical specialty)
Summary Objective Congenital hypogonadotropic hypogonadism with anosmia (Kallmann syndrome) or with normal sense of smell is a heterogeneous genetic disorder caused by defects in the synthesis, secretion and action of gonadotrophin‐releasing hormone (GnRH). Mutations involving autosomal genes have been identified in approximately 30% of all cases of hypogonadotropic hypogonadism. However, most studies that screened patients with hypogonadotropic hypogonadism for gene mutations did not include gene dosage methodologies. Therefore, it remains to be determined whether patients without detected point mutation carried a heterozygous deletion of one or more exons. Measurements We used the multiplex ligation‐dependent probe amplification (MLPA) assay to evaluate the potential contribution of heterozygous deletions of FGFR1 , GnRH1 , GnRHR , GPR54 and NELF genes in the aetiology of GnRH deficiency. Patients We studied a mutation‐negative cohort of 135 patients, 80 with Kallmann syndrome and 55 with normosmic hypogonadotropic hypogonadism. Results One large heterozygous deletion involving all FGFR1 exons was identified in a female patient with sporadic normosmic hypogonadotropic hypogonadism and mild dimorphisms as ogival palate and cavus foot. FGFR1 hemizygosity was confirmed by gene dosage with comparative multiplex and real‐time PCRs. Conclusions FGFR1 or other autosomal gene deletion is a possible but very rare event and does not account for a significant number of sporadic or inherited cases of isolated GnRH deficiency.